Skip to main content

Table 2 Laboratory investigations of the studied groups

From: Endoscopic injection sclerotherapy versus N-Butyl-2 Cyanoacrylate injection in the management of actively bleeding esophageal varices: a randomized controlled trial

Variables Sclerotherapy group (N:56) (Range) Mean ± S.D Cyanoacrylate group (N: 57) (Range) Mean ± S.D P- value
Hemoglobin (g/dl) (3.6–9.8) (4.1–10.3) 0.399
6.87 ± 1.34 7.11 ± 1.62  
WBCs × 109/L (1.9–8.2) (2–12.6) 0.142
4.64 ± 1.54 4.21 ± 1.57  
Platelets ×  109/L (32–172) (27–214) 0.107
84.30 ± 33.31 95.61 ± 40.33  
AST (U/L) (25–169) (18–147) 0.143
54.41 ± 26.73 62.96 ± 34.37  
ALT (U/L) (17–154) (15–132) 0.120
46.54 ± 24.36 54.72 ± 30.75  
Serum bilirubin (mg/dl) (1.2–7.4) (1.5–8.5) 0.440
2.34 ± 1.15 2.53 ± 1.46  
Serum albumin (g/dl) (1.8–3.9) (1.8–4.1) 0.554
2.76 ± 0.59 2.69 ± 0.65  
INR (1.1–2.7) (1.1–2.8) 0.405
1.66 ± 0.55 1.58 ± 0.56  
Serum creatinine (mg/dl) (0.7–3.1) (0.7–2.8) 0.484
1.17 ± 0.41 1.22 ± 0.34  
Blood urea (mg/dl) (19–161) (16–128) 0.605
32.29 ± 19.88 34.04 ± 15.76  
  1. WBCs white blood cells, AST aspartate transaminase, ALT alanine transaminase, INR international normalized ratio